immixbio.com
#4,279,310
Global Rankeez rank — last updated 01 Nov 2026
Better than 95.7% of the 100,511,422 domains we track
Best rank recorded
#4,279,310
2026-11
Worst rank recorded
#11,346,955
2026-08
Tracked since
2026-07
4 monthly snapshots
Source breakdown
Rankeez combines several independent public rankings. Here's how immixbio.com scores in each:
| Source | Rank |
|---|---|
| Tranco (research-grade ranking, resistant to manipulation) | #4,179,580 |
| CommonCrawl (hyperlink graph) | #6,777,989 |
See how these sources are combined and cross-validated →
Ranking history
immixbio.com's rank across 4 monthly snapshots. ▲ improved by 5,511,988 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #9,791,298 |
| 2026-08 | #11,346,955 |
| 2026-10 | #6,851,548 |
| 2026-11 | #4,279,310 |
JSON API
{
"immixbio.com": 4279310,
"history": {
"2026-07": 9791298,
"2026-08": 11346955,
"2026-10": 6851548,
"2026-11": 4279310
}
}
GET https://rankeez.com/api/immixbio.com.json · see API docs →
More about immixbio.com
immixbio.com — page content & similar sites →
Immix Biopharma Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2 PressRelease Corporate Presentation NEXICART-1 ASGCT 2024 Clinical Results Recent Key Opinion Leader Event NEXICART-1 ASH Dec 2023 Clinical Results...
immixbio.com — full site profile →
WHOIS, tech stack and extended traffic history for immixbio.com.